(Q38547588)

4 September 2017

1 reference

title

Reflections on inositol(s) for PCOS therapy: steps toward success (English)

1 reference

4 September 2017

John E Nestler

1

1 reference

4 September 2017

Vittorio Unfer

series ordinal

2

1 reference

4 September 2017

publication date

15 July 2015

1 reference

Gynecological Endocrinology

4 September 2017

published in

1 reference

4 September 2017

volume

31

1 reference

4 September 2017

issue

7

1 reference

4 September 2017

page(s)

501-505

1 reference

Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Insulin sensitizers for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Insulin-sensitizing agents in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Turtles All the Way: Reflections on myo-Inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

myo-Inositol-1,2,3,4,5,6-hexakisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Insulin mediators: structure and formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Polycystic ovary syndrome: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

The D-chiro-inositol paradox in the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1054802

10.3109/09513590.2015.1054802

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference